JP Morgan Chase
OKUR

JP Morgan Chase’s OnKure Therapeutics OKUR Stock Holding History

JP Morgan Chase’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$171 Sell
45
-500
-92% -$1.54K ﹤0.01% 7270
2025
Q4 		$1.58K Buy
545
+122
+29% +$365 ﹤0.01% 6978
2025
Q3 		$1.16K Buy
423
+269
+175% +$666 ﹤0.01% 6975
2025
Q2 		$368 Sell
154
-77
-33% -$202 ﹤0.01% 6729
2025
Q1 		$993 Sell
231
-106
-31% -$596 ﹤0.01% 6631
2024
Q4 		$2.9K Sell
337
-430
-56% -$6.51K ﹤0.01% 6593
2024
Q3 		$13K Sell
767
-25
-3% -$370 ﹤0.01% 6320
2024
Q2 		$12K Sell
792
-712
-47% -$12.1K ﹤0.01% 6224
2024
Q1 		$25K Sell
1,504
-114
-7% -$1.88K ﹤0.01% 6168
2023
Q4 		$25.9K Buy
1,618
+763
+89% +$47.5K ﹤0.01% 6190
2023
Q3 		$65.1K Buy
855
+84
+11% +$5.71K ﹤0.01% 5705
2023
Q2 		$50.6K Sell
771
-1,207
-61% -$97.2K ﹤0.01% 5718
2023
Q1 		$118K Buy
1,978
+31
+2% +$1.12K ﹤0.01% 5350
2022
Q4 		$45K Sell
1,947
-689
-26% -$18.3K ﹤0.01% 5665
2022
Q3 		$88K Buy
+2,636
New +$86.6K ﹤0.01% 5340
2022
Q2 		– Sell
-408
Closed -$12K – 6960
2022
Q1 		$12K Buy
408
+164
+67% +$9.18K ﹤0.01% 6180
2021
Q4 		$21K Sell
244
-68
-22% -$4.99K ﹤0.01% 6206
2021
Q3 		$23K Sell
312
-467
-60% -$39.6K ﹤0.01% 6022
2021
Q2 		$73K Buy
+779
New +$86.9K ﹤0.01% 5636

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

JP Morgan Chase's OKUR Position: Q1 2026 in Review

JP Morgan Chase reduced its OnKure Therapeutics (OKUR) stake by 92% in Q1 2026, selling an estimated $1.54K and leaving 45 shares worth $171. The position accounts for ﹤0.01% of the portfolio, ranked #7270.

JP Morgan Chase first reported a position in OKUR in Q2 2021 and has held it in 19 quarters since. The position peaked at $118K in Q1 2023. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • JP Morgan Chase held 45 shares of OnKure Therapeutics worth $171 as of Q1 2026.
  • JP Morgan Chase sold 500 OnKure Therapeutics shares in Q1 2026, an estimated $1.54K.
  • OnKure Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7270 holding.
  • JP Morgan Chase first reported a position in OnKure Therapeutics in Q2 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's OnKure Therapeutics position peaked at $118K in Q1 2023.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.